These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice. Duperret EK; Trautz A; Ammons D; Perales-Puchalt A; Wise MC; Yan J; Reed C; Weiner DB Clin Cancer Res; 2018 Mar; 24(5):1190-1201. PubMed ID: 29269377 [No Abstract] [Full Text] [Related]
27. Combined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8 Liu Y; Zhang T; Zhang L; Zhao C; Zhang Z; Wang Z; Gu M; Li W; Li B Immunotherapy; 2022 Jun; 14(9):695-708. PubMed ID: 35574588 [TBL] [Abstract][Full Text] [Related]
29. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1. D'Alterio C; Buoncervello M; Ieranò C; Napolitano M; Portella L; Rea G; Barbieri A; Luciano A; Scognamiglio G; Tatangelo F; Anniciello AM; Monaco M; Cavalcanti E; Maiolino P; Romagnoli G; Arra C; Botti G; Gabriele L; Scala S J Exp Clin Cancer Res; 2019 Oct; 38(1):432. PubMed ID: 31661001 [TBL] [Abstract][Full Text] [Related]
30. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a Ren J; Xu M; Chen J; Ding J; Wang P; Huo L; Li F; Liu Z Theranostics; 2021; 11(1):304-315. PubMed ID: 33391476 [No Abstract] [Full Text] [Related]
31. Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody. Katoh Y; Yaguchi T; Kubo A; Iwata T; Morii K; Kato D; Ohta S; Satomi R; Yamamoto Y; Oyamada Y; Ouchi K; Takahashi S; Ishioka C; Matoba R; Suematsu M; Kawakami Y J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793868 [TBL] [Abstract][Full Text] [Related]
32. Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8 Shan CK; Du YB; Zhai XT; Wang YX; Li Y; Gong JH; Ge ZJ; Liu XJ; Zhen YS Cancer Chemother Pharmacol; 2021 Mar; 87(3):425-436. PubMed ID: 33388950 [TBL] [Abstract][Full Text] [Related]
33. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy. Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827 [TBL] [Abstract][Full Text] [Related]
34. Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics. Wen X; Xu P; Shi M; Liu J; Zeng X; Zhang Y; Shi C; Li J; Guo Z; Zhang X; Khong PL; Chen X Theranostics; 2022; 12(1):422-433. PubMed ID: 34987657 [No Abstract] [Full Text] [Related]
35. Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. Fischer E; Chaitanya K; Wüest T; Wadle A; Scott AM; van den Broek M; Schibli R; Bauer S; Renner C Clin Cancer Res; 2012 Nov; 18(22):6208-18. PubMed ID: 22992515 [TBL] [Abstract][Full Text] [Related]
36. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis. Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026 [TBL] [Abstract][Full Text] [Related]
37. Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer. Yuan M; Zhai Y; Men Y; Zhao M; Sun X; Ma Z; Bao Y; Yang X; Sun S; Liu Y; Zhang W; Hui Z Oxid Med Cell Longev; 2022; 2022():5479491. PubMed ID: 35154567 [TBL] [Abstract][Full Text] [Related]
38. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway. Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223 [TBL] [Abstract][Full Text] [Related]
39. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
40. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV Dorta-Estremera S; Hegde VL; Slay RB; Sun R; Yanamandra AV; Nicholas C; Nookala S; Sierra G; Curran MA; Sastry KJ J Immunother Cancer; 2019 Sep; 7(1):252. PubMed ID: 31533840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]